A detailed history of Pnc Financial Services Group, Inc. transactions in Axonics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 391 shares of AXNX stock, worth $27,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares
391
Previous 513 23.78%
Holding current value
$27,753
Previous $34,000 20.59%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$67.3 - $69.67 $8,210 - $8,499
-122 Reduced 23.78%
391 $27,000
Q2 2024

Aug 09, 2024

SELL
$66.47 - $69.65 $176,610 - $185,060
-2,657 Reduced 83.82%
513 $34,000
Q1 2024

May 10, 2024

BUY
$56.67 - $69.36 $174,373 - $213,420
3,077 Added 3308.6%
3,170 $218,000
Q4 2023

Feb 09, 2024

SELL
$49.38 - $63.75 $57,922 - $74,778
-1,173 Reduced 92.65%
93 $5,000
Q3 2023

Nov 13, 2023

SELL
$48.64 - $62.51 $4,669 - $6,000
-96 Reduced 7.05%
1,266 $71,000
Q2 2023

Aug 11, 2023

BUY
$47.99 - $60.21 $4,703 - $5,900
98 Added 7.75%
1,362 $68,000
Q1 2023

May 15, 2023

BUY
$52.6 - $67.34 $5,154 - $6,599
98 Added 8.4%
1,264 $68,000
Q4 2022

Feb 10, 2023

SELL
$59.56 - $76.6 $11,018 - $14,170
-185 Reduced 13.69%
1,166 $72,000
Q3 2022

Nov 10, 2022

BUY
$57.96 - $78.12 $18,141 - $24,451
313 Added 30.15%
1,351 $95,000
Q2 2022

Aug 12, 2022

SELL
$39.5 - $64.42 $3,041 - $4,960
-77 Reduced 6.91%
1,038 $58,000
Q1 2022

May 12, 2022

BUY
$43.74 - $62.76 $5,030 - $7,217
115 Added 11.5%
1,115 $69,000
Q4 2021

Feb 11, 2022

SELL
$50.01 - $73.35 $750 - $1,100
-15 Reduced 1.48%
1,000 $56,000
Q3 2021

Nov 05, 2021

BUY
$59.21 - $78.66 $888 - $1,179
15 Added 1.5%
1,015 $66,000
Q1 2019

May 10, 2019

BUY
$13.32 - $24.35 $13,320 - $24,350
1,000 New
1,000 $0

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.